Science Read the original on Sciencedaily 2 min read 0

Vitamin A and thyroid hormones shape human central vision

Scientists at Johns Hopkins University have identified a specific biological mechanism that enables humans to develop sharp central vision during fetal development. By observing lab-grown retinal tissue, the team discovered that vitamin A derivatives and thyroid hormones coordinate to transform light-sensing cells in the foveola. This breakthrough challenges long-held theories about retinal formation and provides a new roadmap for developing cell therapies to treat age-related vision loss.

#biology #ophthalmology #virology #biotechnology #Johns Hopkins
Чоловік дивиться крізь скляну чашку Петрі з рожевою рідиною, яку тримає рука в фіолетовій медичній рукавичці.
Чоловік дивиться крізь скляну чашку Петрі з рожевою рідиною, яку тримає рука в фіолетовій медичній рукавичці. · Image source: Sciencedaily

According to Sciencedaily, researchers at Johns Hopkins University have uncovered a surprising biological process that dictates how humans develop sharp central vision before birth. The study identifies a precisely timed interaction between thyroid hormones and molecules derived from vitamin A within the retina. This discovery is significant because it provides a clearer understanding of the foveola, the tiny region responsible for approximately half of all human visual perception.

Mechanisms of Retinal Development

The research team utilized retinal organoids—small clusters of tissue grown from fetal cells that mimic human retinal structures—to observe cellular changes over several months. They focused specifically on cone photoreceptors, which are responsible for daytime and color vision. While the rest of the retina contains a mix of blue, green, and red cones, the foveola is unique because it contains only red and green cones to facilitate high-acuity sight.

The study revealed that this specialized arrangement occurs through a two-step sequence during fetal development between weeks 10 and 14:

  • Retinoic acid, a molecule derived from vitamin A, is broken down to limit the formation of new blue cones.
  • Thyroid hormones then act on the remaining blue cone cells, driving them to convert into red and green cones.
  • This coordinated transition ensures that blue cones do not persist in the foveola, which would otherwise impair visual clarity.

Challenging Existing Scientific Models

For decades, scientists struggled to explain this process because common laboratory models, such as mice and fish, do not develop the same photoreceptor arrangements as humans. The new findings suggest that rather than blue cones migrating away from the center of the retina, they undergo a physical transformation into other types.

"First, retinoic acid helps set the pattern. Then, thyroid hormone plays a role in converting the leftover cells," — Robert J. Johnston Jr., an associate professor of biology at Johns Hopkins who led the research.p>

Implications for Vision Restoration

Understanding these specific pathways is critical for addressing conditions like macular degeneration and glaucoma, which primarily damage the central retina. By mastering how these cells transform in a lab setting, scientists hope to eventually grow and transplant functional retinal tissues. This research provides a foundational step toward creating biologically accurate organoids that could one day restore sight to those with degenerative eye diseases.

FAQ

What is the role of the foveola in human vision?
The foveola is a tiny region responsible for approximately half of all human visual perception. It contains only red and green cones to facilitate high-acuity sight, which ensures clear central vision.
How do blue cones change during fetal development?
Between weeks 10 and 14 of fetal development, retinoic acid limits new blue cone formation. Thyroid hormones then act on the remaining blue cone cells, driving them to physically transform into red and green cones.
Why is this research important for eye diseases?
Understanding these specific pathways helps address conditions like macular degeneration and glaucoma which damage the central retina. Scientists hope to use this knowledge to grow and transplant functional retinal tissues to restore sight.
Telegram

Fresh news on our Telegram

Get instant alerts for new posts in «Science»

@proscienceandevenmore